Abstract
Nine children with acute typical post-diarrhea hemolytic uremic syndrome (HUS) were treated with intravenous gammaglobulin (IVIG). These children were compared to nine children with HUS who did not receive IVIG. The use of IVIG did not appear to have a beneficial effect on eight of the nine treated children. There were no significant differences found in the duration of hemorrhagic colitis, thrombocytopenia, elevation of the white blood count (WBC), anuria, dialysis, or hospitalization, or the presence of a central nervous system complication or pancreatitis. Although no significant difference was found in the duration of thrombocytopenia, there was a trend towards a longer duration of thrombocytopenia in children treated with IVIG (P=0.13). One child demonstrated both an increase in her platelet count and a decrease in her WBC count within 24 h of receiving her first dose of IVIG.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cleary TC (1988) Cytotoxin-producingEscherichia coli and the hemolytic uremic syndrome. Pediatr Clin North Am 35:485–501
Srivastava RN (1987) Pediatric renal problems in India. Pediatr Nephrol 1:238–244
Karmali MA, Steele BT, Petric M, Lim C (1983) Sporadic cases of haemolytic-uremic syndrome associated with faecal cytotoxin and cytotoxin-producingEscherichia coli in stools. Lancet I:619–620
Ashkenazi S, Cleary TG, Lopez E, Ackering LK (1988) Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. J Pediatr 113:1008–1014
Bitzan M, Klemt M, Altrogge H (1989) Immunotherapy for hemolytic-uremic syndrome: different efficiencies of therapeutic immunoglobulins to neutralize Shiga-like toxin I and II (abstract). Pediatr Nephrol 3:C182
Grodinski A, Telmesani A, Robson WLM, Fick G, Scott RB (1991) The gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr (1990) Vol 2:518–524
Robson WLM, Fick GH, Wilson PCG (1988) Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome. Child Nephrol Urol 9:203–207
Sheth KJ, Gill JC, Leichter HE (1990) High-dose intravenous gamma globulin infusions in hemolytic uremic syndrome: a preliminary report. Am J Dis Child 144:268–270
Head SC, Karmali MA, Roscoe ME, Petric M, Strockbine NA, Wachsmuth IK (1988) Serological differences between verocytotoxin 2 and shiga-like toxin II. Lancet II:751
Milford DV, Taylor CM, Rose PE, Roy TCF, Rowe B (1989) Immunologic therapy for hemolytic-uremic syndrome. J Pediatr 115: 502–503
Richardson SE, Petric M, Karmali MA (1988) Uptake of 125 I-labeled verotoxin into rabbits (abstract). Annu Meet Am Soc Microbiol B35:35
Walters MDS, Ute Matthei L, Kay R, Dillon MJ, Barratt TM (1989) The polymorphonuclear leukocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3:130–134
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robson, W.L.M., Fick, G.H., Jadavji, T. et al. The use of intravenous gammaglobulin in the treatment of typical hemolytic uremic syndrome. Pediatr Nephrol 5, 289–292 (1991). https://doi.org/10.1007/BF00867478
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00867478